Patrick Smith Sells 10,000 Shares of Axon Enterprise (NASDAQ:AXON) Stock

Axon Enterprise, Inc (NASDAQ:AXONGet Free Report) CEO Patrick Smith sold 10,000 shares of the business’s stock in a transaction that occurred on Tuesday, October 7th. The shares were sold at an average price of $713.74, for a total value of $7,137,400.00. Following the completion of the transaction, the chief executive officer directly owned 3,033,982 shares in the company, valued at approximately $2,165,474,312.68. This trade represents a 0.33% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

Axon Enterprise Trading Up 0.9%

Shares of Axon Enterprise stock opened at $734.04 on Friday. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.95 and a quick ratio of 2.71. The firm has a market cap of $57.63 billion, a PE ratio of 181.24, a P/E/G ratio of 28.25 and a beta of 1.41. Axon Enterprise, Inc has a 1 year low of $422.38 and a 1 year high of $885.91. The stock has a fifty day moving average price of $756.36 and a 200-day moving average price of $711.76.

Axon Enterprise (NASDAQ:AXONGet Free Report) last issued its earnings results on Monday, August 4th. The biotechnology company reported $2.12 EPS for the quarter, topping the consensus estimate of $1.54 by $0.58. The business had revenue of $668.54 million during the quarter, compared to the consensus estimate of $641.77 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The firm’s revenue was up 32.6% compared to the same quarter last year. During the same quarter last year, the company earned $1.20 EPS. Axon Enterprise has set its FY 2025 guidance at EPS. Equities research analysts anticipate that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Hedge Funds Weigh In On Axon Enterprise

Large investors have recently bought and sold shares of the business. TCTC Holdings LLC boosted its stake in Axon Enterprise by 75.0% in the first quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock valued at $29,000 after acquiring an additional 24 shares in the last quarter. Bartlett & CO. Wealth Management LLC increased its stake in shares of Axon Enterprise by 132.0% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company’s stock worth $31,000 after purchasing an additional 33 shares in the last quarter. Banque Transatlantique SA purchased a new position in shares of Axon Enterprise during the 1st quarter worth approximately $31,000. Catalyst Capital Advisors LLC purchased a new stake in Axon Enterprise in the 1st quarter worth approximately $32,000. Finally, Flaharty Asset Management LLC purchased a new stake in shares of Axon Enterprise during the 1st quarter valued at $33,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Analysts Set New Price Targets

AXON has been the subject of several recent analyst reports. Zacks Research cut Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 2nd. Craig Hallum raised Axon Enterprise from a “hold” rating to a “buy” rating and set a $900.00 price target for the company in a research note on Tuesday, August 5th. Piper Sandler initiated coverage on Axon Enterprise in a research note on Tuesday, September 23rd. They issued an “overweight” rating and a $893.00 price objective for the company. Northland Securities set a $800.00 price objective on Axon Enterprise in a report on Tuesday, August 5th. Finally, Morgan Stanley set a $885.00 target price on Axon Enterprise and gave the company an “overweight” rating in a research report on Friday, July 11th. Fourteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $841.64.

Check Out Our Latest Analysis on Axon Enterprise

About Axon Enterprise

(Get Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Further Reading

Insider Buying and Selling by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.